PATENT CLAIM ANALYSIS

Application Number: 15908367
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "449000"]

Abstract:
The present invention relates to a stable liquid formulation of cabazitaxel. The formulation comprises cabazitaxel and at least one solubilizer. Typically, formulations are in the form of ready-to-use solutions or concentrates.

Claim (Index 12):
The pharmaceutical solution according to  claim 10 , wherein the cabazitaxel or pharmaceutically acceptable salt thereof is present at a concentration of about 5 mg/mL to about 200 mg/mL.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 88.0
- Lexical Diversity: 1.2069
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15824557', '15342457', '12721564', '13967822', '14087903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7823692075332294
- 35 USC 102 Novelty (BERT): 0.513613642165321
- Combined Prediction Score: 0.7554936509964386
- Mean Citation Score: 245.68354
- Max Citation Score: 270.4332
- Similarity Product: 175.86716583967208

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test